Evidence map›Paper›PMID 22871340›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2012

Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells.

M A Poreba, C X Dong, S K Li, A Stahl, J H Miner, P L Brubaker

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. The metabolic role of vagal afferent innervation.Nature reviews. Gastroenterology & hepatology · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Stimulation of incretin secreting cells.Therapeutic advances in endocrinology and metabolism · 2016
    Review
  16. The anti-obesity drug orlistat reveals anti-viral activity.Medical microbiology and immunology · 2015
    Article
  17. Gut chemosensing mechanisms.The Journal of clinical investigation · 2015
    Review
  18. The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Review
  19. Article
  20. The gut as a sensory organ.Nature reviews. Gastroenterology & hepatology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

M A PorebaDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
C X Dong
S K Li
A Stahl
J H Miner
P L Brubaker
University of California, Berkeley · USUniversity of Toronto · CAWashington University in St. Louis · US

Funding

Role of FATP4 in Skin DevelopmentR01AR049269 · NIAMS · WASHINGTON UNIVERSITY · PI MINER, JEFFREY H · 2003 to 2012
$2.4M
CIHRNIAMS NIH HHS R01 AR049269NIAMS NIH HHS R01-AR-049269
6 · The paper itself

Abstract

The antidiabetic intestinal L cell hormone glucagon-like peptide-1 (GLP-1) enhances glucose-dependent insulin secretion and inhibits gastric emptying. GLP-1 secretion is stimulated by luminal oleic acid (OA), which crosses the cell membrane by an unknown mechanism. We hypothesized that L cell fatty acid transport proteins (FATPs) are essential for OA-induced GLP-1 release. Therefore, the murine GLUTag L cell model was used for immunoblotting, [(3)H]OA uptake assay, and GLP-1 secretion assay as determined by radioimmunoassay following treatment with OA ± phloretin, sulfo-N-succinimidyl oleate, or siRNA against FATP4. FATP4(-/-) and cluster-of-differentiation 36 (CD36)(-/-) mice received intraileal OA, and plasma GLP-1 was measured by sandwich immunoassay. GLUTag cells were found to express CD36, FATP1, FATP3, and FATP4. The cells demonstrated specific (3)H[OA] uptake that was dose-dependently inhibited by 500 and 1,000 μM unlabeled OA (P < 0.001). Cell viability was not altered by treatment with OA. Phloretin and sulfo-N-succinimidyl oleate, inhibitors of protein-mediated transport and CD36, respectively, also decreased [(3)H]OA uptake, as did knockdown of FATP4 by siRNA transfection (P < 0.05-0.001). OA dose-dependently increased GLP-1 secretion at 500 and 1,000 μM (P < 0.001), whereas phloretin, sulfo-N-succinimidyl oleate, and FATP4 knockdown decreased this response (P < 0.05-0.01). FATP4(-/-) mice displayed lower plasma GLP-1 at 60 min in response to intraileal OA (P < 0.05), whereas, unexpectedly, CD36(-/-) mice displayed higher basal GLP-1 levels (P < 0.01) but a normal response to intraileal OA. Together, these findings demonstrate a key role for FATP4 in OA-induced GLP-1 secretion from the murine L cell in vitro and in vivo, whereas the precise role of CD36 remains unclear.

Indexed as

AnimalsCD36 AntigensCells, CulturedEnteroendocrine CellsFatty Acid Transport ProteinsFemaleGene SilencingGlucagon-Like Peptide 1MaleMiceMice, Inbred C57BLOleic AcidOleic AcidsPhloretinSuccinimidesCD36 AntigensFatty Acid Transport ProteinsGlucagon-Like Peptide 1Oleic AcidOleic AcidsPhloretinSlc27a1 protein, mouseSlc27a4 protein, mouseSuccinimidessulfo-N-succinimidyl oleate

Identifiers

PMID22871340
PMCPMC3469616
OpenAlexW2103337198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.